Socioeconomic Disparities in Women's Cardiovascular Health in United States and Canada

G Kaur, D Masket, T Reddy, S Revankar… - Canadian Journal of …, 2024 - Elsevier
Cardiovascular disease has been the leading cause of death in the United States and
Canada for decades. Although it affects millions across a multitude of backgrounds, notable …

Aging in Heart Failure: Embracing Biology Over Chronology: JACC Family Series

P Goyal, MS Maurer, J Roh - JACC: Heart Failure, 2024 - Elsevier
Age is among the most potent risk factors for developing heart failure and is strongly
associated with adverse outcomes. As the global population continues to age and the …

Short-Stay Units vs Routine Admission From the Emergency Department in Patients With Acute Heart Failure: The SSU-AHF Randomized Clinical Trial

PS Pang, DA Berger, SA Mahler, X Li… - JAMA Network …, 2024 - jamanetwork.com
Importance More than 80% of patients who present to the emergency department (ED) with
acute heart failure (AHF) are hospitalized. With more than 1 million annual hospitalizations …

Association of High-Density Lipoprotein Parameters and Risk of Heart Failure: A Multicohort Analysis

A Pandey, KV Patel, MW Segar, MD Shapiro… - JACC: Heart Failure, 2024 - Elsevier
Background High-density lipoprotein (HDL) is commonly characterized by its cholesterol
concentration (HDL-C) and inverse association with atherosclerotic cardiovascular disease …

2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology …

TM Maddox, JL Januzzi Jr, LA Allen, K Breathett… - Journal of the American …, 2024 - jacc.org
The 2021 Update to the 2017 American College of Cardiology (ACC) Expert Consensus
Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues …

The HFSA advanced heart failure and transplant cardiology Fellowship Consensus Conference

MH Drazner, AV Ambardekar, K Berlacher… - Journal of Cardiac …, 2024 - Elsevier
There is waning interest among cardiology trainees in pursuing an Advanced Heart
Failure/Transplant Cardiology (AHFTC) fellowship as evidenced by fewer applicants in the …

[HTML][HTML] SGLT2 inhibitors: Beyond glycemic control

I Hasan, T Rashid, V Jaikaransingh, C Heilig… - Journal of Clinical & …, 2024 - Elsevier
Multiple randomized controlled trials have extensively examined the therapeutic
effectiveness of sodium-glucose cotransporter 2 (SGLT2) inhibitors, ushering in a …

Differences in donor heart acceptance by race and gender of patients on the transplant waiting list

K Breathett, SM Knapp, SC Lewsey, SF Mohammed… - JAMA, 2024 - jamanetwork.com
Importance Barriers to heart transplant must be overcome prior to listing. It is unclear why
Black men and women remain less likely to receive a heart transplant after listing than White …

SGLT2 Inhibitors, Functional Capacity, and Quality of Life in Patients With Heart Failure: A Systematic Review and Meta-Analysis

M Gao, K Bhatia, A Kapoor, J Badimon… - JAMA Network …, 2024 - jamanetwork.com
Importance The associations of sodium glucose cotransporter-2 inhibitors (SGLT2is) with
reduction in mortality and hospitalization rates in patients with heart failure (HF) are well …

[HTML][HTML] Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future

S Zhou, Y Liu, X Huang, C Wu… - Frontiers in …, 2024 - frontiersin.org
Heart failure, a prevailing global health issue, imposes a substantial burden on both
healthcare systems and patients worldwide. With an escalating prevalence of heart failure …